by Lauren Amphlett | Mar 5, 2024 | General interest, Information and Learning, Latest research news, Lifestyle and Coping Skills, Living with Aspergillosis, Patient stories
Navigating the rollercoaster of chronic illness is a unique and often isolating experience. It is a journey that can be filled with uncertainties, regular hospital appointments, and a never-ending quest for a return to normal. This is so often the reality for...
by Lauren Amphlett | Nov 6, 2023 | General interest, Information and Learning, Latest research news
We’re excited to share that there’s a new clinical study that’s looking into an innovative treatment specifically for individuals dealing with both asthma and ABPA. This treatment comes in the form of an inhaler called PUR1900. What is PUR1900?...
by Lauren Amphlett | Oct 27, 2023 | General interest, Latest research news
In a remarkable advancement towards treating Chronic Obstructive Pulmonary Disease (COPD), scientists have, for the first time, demonstrated the potential of repairing damaged lung tissue using patients’ own lung cells. The breakthrough was unveiled at this...
by Seren Evans | Apr 19, 2023 | General interest, Latest research news
Excess mucus production is a common problem in people with Allergic Bronchopulmonary Aspergillosis (ABPA), and chronic pulmonary aspergillosis (CPA). Mucus is a thick mixture of water, cellular debris, salt, lipids, and proteins. It lines our airways, trapping and...
by Seren Evans | Mar 22, 2023 | Antifungals in development, General interest, Latest research news
The numbers of people at risk of fungal infections are increasing due to an aging population, increased use of immunosuppressive medications, pre-existing medical conditions, environmental changes, and lifestyle factors. Therefore, there is a growing need for new...
by Seren Evans | Mar 9, 2023 | Antifungals in development, General interest, Latest research news
ABPA (Allergic Bronchopulmonary Aspergillosis) is a serious allergic disease caused by a fungal infection of the airways. People with ABPA usually have severe asthma and frequent flare-ups that often require long-term use of oral steroids and antibiotics to treat...